Abstract
Abstract Alopecia Areata is a patchy hair loss from autoimmune-mediated destruction of hair follicles, for which there is no adequate therapy. PTH-CBD is a fusion protein of parathyroid hormone and a bacterial collagen-binding domain, providing targeted delivery of a hair cycle stimulator to skin and promoting hair growth. Objectives: We tested the effects of PTH-CBD on hair growth in an established animal model for alopecia areata, the C3H/HeJ engrafted mouse. Methods: C3H/HeJ engrafted mice (Jackson Laboratories, Bar Harbor, ME) were treated subcutaneously for 8 weeks with either vehicle or different doses of PTH-CBD (320 mcg/kg x1, 1000 mcg/kg x1 or 1000 mcg/kg/wk). Results: Vehicle animals showed progressive hair loss, as expected. In PTH-CBD treated animals, grey scale quantification showed a greater proportion of PTH-CBD treated animals without significant hair loss at the end of the 2 month period (18/22 PTH-CBD vs. 4/11 vehicle), with no observed differences between the different PTH-CBD treatment regimens. Histological examination revealed no change in CD8+ cells, but there was a marked increases in the number of anagen VI hair follicles in PTH-CBD treated animals. There were also increased levels of betacatenin, a known initiator of the hair cycle, observed around the bulge region of hair follicles. Conclusions: C3H/HeJ engrafted animals treated with PTH-CBD showed rapid and persistent improvements in hair growth in the majority of tested animals. There were marked increases in anagen hair follicles despite an ongoing immune reaction. Increased beta catenin levels suggest that PTH-CBD stimulates hair growth by activating the Wnt pathway.
Highlights
Alopecia areata is an autoimmune-mediated destruction of anagen phase hair follicles which leads to patchy hair loss [1]
Alopecia areata is caused by T cell-mediated autoimmune destruction of hair follicles [6], with a predominantly CD8+ lymphocyte infiltrate resulting in hair loss [7,8]
We have previously shown that parathyroid hormone (PTH)-collagen binding domain (CBD) is effective at preventing or reversing chemotherapy-induced hair loss, and causes marked increase in the number of anagen hair follicles [33,34]
Summary
Alopecia areata is an autoimmune-mediated destruction of anagen phase hair follicles which leads to patchy hair loss [1]. It is a common form of hair loss and affects 2.1% of population [2]. A new study using human clinical samples and a mouse model demonstrates that NKG2D (+) T effector memory cells, part of CD8+ lymphocyte family mediate alopecia areata; through Janus kinase (JAK) signaling. Based on this mechanism, alopecia areata can be treated with JAK inhibitors [9, 10]. While we know many of the details of the immunologic pathways in the development of the autoimmune reaction for alopecia areata, the antigenic triggers for this immune reaction have not yet been identified, nor has the time course for the development of this reaction been defined
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of Clinical & Experimental Dermatology Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.